In this article, patent attorney Vivian Wei Cheng discusses patent term extension in the association of Southeast Asian nations (ASEAN), a globally important group.
The grant of a 20-year exclusive monopoly on a patented invention to a patent proprietor is done so in exchange for a full disclosure of the novel and inventive invention and how it may be worked.
Greenwashing, the act of making false or misleading claims about the environmental benefits of products or services, is not a new phenomenon in Singapore.
The Intellectual Property (Amendment) Bill is expected to come into effect in May 2022, introducing amendments to a host of current IP acts. We outline the various changes, detailing what these could mean for improving operational efficiency, and legislative and procedural clarity, for business registering IP assets in Singapore
On 12 January 2022, the Intellectual Property (Amendment) Bill was passed in Parliament and is expected to come into effect in May 2022.
The Asia Pacific region is a significant emerging patent market for pharma companies. Our latest article explores the key differences to note in how medical use claims may be construed in various jurisdictions in the region.
In Singapore, amendments have been introduced to the Singapore Patent Rules from 1 October 2021 to formalise pre-grant third party observations and to introduce post-grant re-examination, with an aim to enhance dispute resolution processes.